Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01540643 · ClinicalTrials.gov registry record
Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
A clinical trial, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 600
- Enrollment target
NCT01540643: Completed study, sponsored by Cook Group Incorporated.
NCT01540643 is a clinical trial that has completed, run by Cook Group Incorporated. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01540643 has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.
Interventions
- DEVICE Iliac Leg Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-03 |
What the finished NCT01540643 record still lists
NCT01540643 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Iliac Leg Graft is the first listed.
NCT01540643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01540643 about?
NCT01540643 is a clinical study titled "Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry". The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.
What is the current status of trial NCT01540643?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2012-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01540643?
The interventions under investigation include: Iliac Leg Graft (DEVICE).
Who is sponsoring clinical trial NCT01540643?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia